STAT3 and carcinoma: An aberrant IL-6/STAT3/lncTCF7 signaling axis, in which IL-6 in tumor microenvironment induces lncTCF7 via activating STAT3, contributes to hapatocellular carcinoma cells aggressiveness through EMT induction [88].